vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Bitcoin Depot Inc. (BTM). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $162.5M, roughly 1.7× Bitcoin Depot Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 3.4%, a 92.9% gap on every dollar of revenue. On growth, Bitcoin Depot Inc. posted the faster year-over-year revenue change (20.1% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -4.9%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.
ACAD vs BTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $162.5M |
| Net Profit | $273.6M | $5.5M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 7.3% |
| Net Margin | 96.3% | 3.4% |
| Revenue YoY | 9.4% | 20.1% |
| Net Profit YoY | 90.3% | 690.4% |
| EPS (diluted) | $1.61 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | — | ||
| Q3 25 | $278.6M | $162.5M | ||
| Q2 25 | $264.6M | $172.1M | ||
| Q1 25 | $244.3M | $164.2M | ||
| Q4 24 | $259.6M | — | ||
| Q3 24 | $250.4M | $135.3M | ||
| Q2 24 | $242.0M | $163.1M | ||
| Q1 24 | $205.8M | $138.5M |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $5.5M | ||
| Q2 25 | $26.7M | $6.1M | ||
| Q1 25 | $19.0M | $4.2M | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | $-939.0K | ||
| Q2 24 | $33.4M | $-2.6M | ||
| Q1 24 | $16.6M | $-1.5M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | 7.3% | ||
| Q2 25 | 12.2% | 9.2% | ||
| Q1 25 | 7.9% | 10.8% | ||
| Q4 24 | 59.1% | — | ||
| Q3 24 | 12.6% | 4.1% | ||
| Q2 24 | 12.6% | 4.7% | ||
| Q1 24 | 7.4% | 0.5% |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | 3.4% | ||
| Q2 25 | 10.1% | 3.5% | ||
| Q1 25 | 7.8% | 2.6% | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | -0.7% | ||
| Q2 24 | 13.8% | -1.6% | ||
| Q1 24 | 8.0% | -1.1% |
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | $0.08 | ||
| Q2 25 | $0.16 | $0.16 | ||
| Q1 25 | $0.11 | $0.20 | ||
| Q4 24 | $0.86 | — | ||
| Q3 24 | $0.20 | $-0.05 | ||
| Q2 24 | $0.20 | $-0.13 | ||
| Q1 24 | $0.10 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $59.3M |
| Total DebtLower is stronger | — | $67.5M |
| Stockholders' EquityBook value | $1.2B | $21.0M |
| Total Assets | $1.6B | $125.3M |
| Debt / EquityLower = less leverage | — | 3.21× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | $59.3M | ||
| Q2 25 | $253.6M | $48.0M | ||
| Q1 25 | $217.7M | $35.0M | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | $32.2M | ||
| Q2 24 | $177.1M | $43.9M | ||
| Q1 24 | $204.7M | $42.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $67.5M | ||
| Q2 25 | — | $66.5M | ||
| Q1 25 | — | $56.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $44.5M | ||
| Q2 24 | — | $41.2M | ||
| Q1 24 | — | $37.6M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $917.3M | $21.0M | ||
| Q2 25 | $822.4M | $4.7M | ||
| Q1 25 | $765.2M | $-4.6M | ||
| Q4 24 | $732.8M | — | ||
| Q3 24 | $577.2M | $-7.9M | ||
| Q2 24 | $516.7M | $4.4M | ||
| Q1 24 | $464.0M | $5.0M |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.3B | $125.3M | ||
| Q2 25 | $1.2B | $109.1M | ||
| Q1 25 | $1.1B | $89.7M | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $976.9M | $87.4M | ||
| Q2 24 | $914.1M | $97.5M | ||
| Q1 24 | $855.1M | $90.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.21× | ||
| Q2 25 | — | 14.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 9.27× | ||
| Q1 24 | — | 7.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $6.6M |
| Free Cash FlowOCF − Capex | — | $2.5M |
| FCF MarginFCF / Revenue | — | 1.6% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | -0.18× | 1.20× |
| TTM Free Cash FlowTrailing 4 quarters | — | $27.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | — | ||
| Q3 25 | $74.3M | $6.6M | ||
| Q2 25 | $64.0M | $10.2M | ||
| Q1 25 | $20.3M | $16.3M | ||
| Q4 24 | $40.4M | — | ||
| Q3 24 | $63.2M | $5.8M | ||
| Q2 24 | $25.0M | $10.1M | ||
| Q1 24 | $29.1M | $1.3M |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | $2.5M | ||
| Q2 25 | — | $9.8M | ||
| Q1 25 | — | $15.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $63.2M | $-1.0M | ||
| Q2 24 | — | $7.6M | ||
| Q1 24 | — | $789.0K |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | 1.6% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | 9.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | -0.8% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 2.5% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | 5.0% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 1.20× | ||
| Q2 25 | 2.40× | 1.67× | ||
| Q1 25 | 1.07× | 3.88× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
BTM
Segment breakdown not available.
